Evidence map›Paper›PMID 37108557›Full record

ArticleInternational journal of molecular sciences2023

Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans.

Alessandro Di Giorgi, Giorgia Sprega, Lourdes Poyatos, Esther Papaseit, Clara Pérez-Mañá, Annagiulia Di Trana, Maria Rosaria Varì, Francesco Paolo Busardò, Simona Pichini, Simona Zaami and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Alessandro Di GiorgiDepartment of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy.
Giorgia SpregaDepartment of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy.
Lourdes PoyatosDepartment of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain.ORCID 0000-0002-4641-8600
Esther PapaseitDepartment of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain.
Clara Pérez-MañáDepartment of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain.ORCID 0000-0001-6343-6918
Annagiulia Di TranaNational Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy.
Maria Rosaria VarìNational Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0001-8641-0761
Francesco Paolo BusardòDepartment of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy.
Simona PichiniNational Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy.
Simona ZaamiDepartment of Anatomical, Histological, Forensic, and Orthopedic Sciences, Università La Sapienza, 00161 Rome, Italy.ORCID 0000-0001-5741-7139
Alfredo Fabrizio Lo FaroDepartment of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy.ORCID 0000-0002-0240-5277
Magí FarréDepartment of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain.ORCID 0000-0001-8338-7543
Marche Polytechnic University · ITUniversitat Autònoma de Barcelona · ESIstituto Superiore di Sanità · ITSapienza University of Rome · IT

Funding

Italian Department of antidrug Policies no number
6 · The paper itself

Abstract

The aim of this study was to determine the excretion of methylone and its metabolites in sweat following the ingestion of increasing controlled doses of 50, 100, 150 and 200 mg of methylone to twelve healthy volunteers involved in a clinical trial. Methylone and its metabolites 4-hydroxy-3-methoxy-N-methylcathinone (HMMC) and 3,4-methylenedioxycathinone (MDC) were analyzed in sweat patches by liquid chromatography-tandem mass spectrometry. Methylone and MDC were detected in sweat at 2 h and reached their highest accumulation (C

Indexed as

MethamphetamineSweatChromatography, LiquidHumansMass SpectrometryMethamphetaminemethyloneLC-MS/MSmethylonepharmacokineticssweat

Identifiers

PMID37108557
PMCPMC10138602
OpenAlexW4366286742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.